All AbMole products are for research use only, cannot be used for human consumption.
Kaempferol 3-O-β-D-glucuronide is a conjugated kaempferol metabolite, which has anti-inflammatory effect. Kaempferol 3-O-β-D-glucuronide significantly inhibits various pro-inflammatory mediators like IL-1β, NO, PGE2, and LTB4.
| Cell Experiment | |
|---|---|
| Cell lines | RAW 264.7 cells |
| Preparation method | RAW 264.7 cells (2×105cells/well) were pretreated with K3G (5 and 10 μM) for 1 h and stimulated with LPS (1 μg/mL) for 24 h. Cells were then harvested. Cell pellet was solubilised in RIPA buffer over ice for 40 min. The lysate was centrifuged at 14,000 g for 15 min at 4 °C. Supernatant was collected. Protein estimation was done by Bradford's method with BSA standard. Western blotting was performed according to the reported protocol. Detection of specific proteins was done by Immobilon Western mediated chemiluminescence by ChemiDoc XRS+. Densitometry of specific bands was done using Image Lab Software version 3. The effect on phosphorylation of NF-kB p65 was studied in a dose dependent manner in comparison to dexamethasone (0.5 μM). |
| Concentrations | 5 and 10 μM |
| Incubation time | 1 h |
| Animal Experiment | |
|---|---|
| Animal models | Female Balb/C mice 10–12 weeks old and weight is 20–25 g |
| Formulation | dissolved in 100% DMSO and the working concentration of DMSO in animals is below 1% |
| Dosages | 1 mg/kg, 2 mg/kg and 5 mg/kg |
| Administration | drugged for 1 h |
| Molecular Weight | 462.36 |
| Formula | C21H18O12 |
| CAS Number | 22688-78-4 |
| Solubility (25°C) | DMSO |
| Storage | 2-8°C, protect from light, dry, sealed |
| Related IL Receptor/Related Products |
|---|
| Reslizumab
Reslizumab (Sch 55700) is a humanized monoclonal antibody targeting human interleukin 5 (IL-5) for the study of eosinophilic asthma. Reslizumab effectively blocks il-5 function. Reslizumab inhibited IL-5-dependent cell proliferation with an IC50 of about 91.1 pM. |
| Montelukast sodium
Montelukast sodium selectively antagonizes leukotriene D 4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1. |
| VGX-1027
VGX-1027 is an orally active immunomodulator. |
| Diacerein
Diacerin is an inhibitor of pro-inflammatory cytokine Interleukin-1B (IL-1B) production, prescribed for osteoarthritis and chronic inflammatory arthritis. |
| SC144
SC144 is the first oral active GP130 (IL6-beta) inhibitor. SC144 binds gp130, induces gp130 phosphorylation (S782) and deglycosylation, eliminates Stat3 phosphorylation and nuclear translocation, and further inhibits downstream target gene expression. SC144 inhibited signal transduction induced by GP130 ligand. SC144 induces apoptosis of human ovarian cancer cells. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
